Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Ali, Talasaz"'
Autor:
David R. Gandara, Stefanie Mortimer, Amir Ali Talasaz, Jonathan W. Riess, Rebekah A. Burich, Christine E. Lee, Oliver A. Zill, Richard B. Lanman, Carin R. Espenschied, Philip C. Mack, Kimberly C. Banks
Publikováno v:
Cancer
Background Circulating cell‐free tumor DNA (ctDNA)‐based mutation profiling, if sufficiently sensitive and comprehensive, can efficiently identify genomic targets in advanced lung adenocarcinoma. Therefore, the authors investigated the accuracy a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96c9c95edac568d8c59a189e19fc97d0
http://europepmc.org/articles/PMC7383626
http://europepmc.org/articles/PMC7383626
Autor:
Anand Pathak, Anand Kolatkar, Amir Ali Talasaz, Julia A. Beaver, Daniel Edelstein, Matthew Ryder, Jerry S.H. Lee, Peter Kuhn, Lea M. Salvatore, Justin Johnson, Seema Singh Bhan, Allison Welsh, David A. Eberhard, James H Godsey, Howard I. Scher, Melanie Hullings, Carolyn Compton, James W. Hicks, Matthew Smalley, Robert L. Grossman, Jonathan W. Simons, Jake Vinson, Gideon M. Blumenthal, David Reese, Sean E. Hanlon, Walt Wells, Rebecca Levine, Phillip G. Febbo, Wendy Royalty, Lauren C. Leiman, Bryan Moy, Hsian-Rong Tseng, Ryan Dittamore, Daniel H. Hovelson, Daniel P. Miller, Anne-Marie Martin, Donald J Johann, Andrew E. Schade, J. Carl Barrett, Hakan Sakul, Carissa Moore, Stella Somiari, Kelli Bramlett, Paul J. Beresford, Andrew Gruen, Reena Philip, John K. Simmons, Angela Silvestro, Jean-Francois Martini, Muneesh Tewari
Publikováno v:
Clinical Pharmacology and Therapeutics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::021e87ff08b0cace4490eeb5f6d29110
http://europepmc.org/articles/PMC7158216
http://europepmc.org/articles/PMC7158216
Autor:
Catalin Barbacioru, Jason Willis, M. Benavides, Marwan Fakih, Jinchul Kim, Jing Zhao, Kabir Mody, Timmy Nguyen, Richard B. Lanman, Jeeyun Lee, Seung Tae Kim, Kyoung-Mee Kim, Daniel V.T. Catenacci, Hyuk Lee, Yoshiaki Nakamura, Ramez N. Eskander, Nir Peled, Danielle Gavino, Darya Chudova, Scott Kopetz, Alexander Artyomenko, Pashtoon Murtaza Kasi, Takayuki Yoshino, Marcin Sikora, Victoria M. Raymond, Georges Azzi, Justin I. Odegaard, Stephen R. Fairclough, Martina I. Lefterova, Mike Cusnir, Kimberly C. Banks, Amir Ali Talasaz
Publikováno v:
Clinical Cancer Research. 25:7035-7045
Purpose:To analytically and clinically validate microsatellite instability (MSI) detection using cell-free DNA (cfDNA) sequencing.Experimental Design:Pan-cancer MSI detection using Guardant360 was analytically validated according to established guide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43359701fade9ac161897323c5683083
https://doi.org/10.1158/1078-0432.ccr-19-1324
https://doi.org/10.1158/1078-0432.ccr-19-1324
Autor:
Norman P. A. Hüner, Alexander G. Ivanov, John L. Barron, Christopher Ward, Ali Talasaz, Bernard Grodzinski, Mark Brophy, Ayan Chaudhury, Rajnikant V. Patel
Publikováno v:
IEEE/ACM Transactions on Computational Biology and Bioinformatics. 16:2009-2022
Machine vision for plant phenotyping is an emerging research area for producing high throughput in agriculture and crop science applications. Since 2D based approaches have their inherent limitations, 3D plant analysis is becoming state of the art fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::503d0d235510452286389905af1c510d
https://doi.org/10.1109/tcbb.2018.2824814
https://doi.org/10.1109/tcbb.2018.2824814
Autor:
Elisa Ledet, Mehmet Asim Bilen, Guru Sonpavde, Petros Grivas, Jue Wang, Rebecca J. Nagy, Michael B. Lilly, Gurudatta Naik, Shilpa Gupta, Amir Ali Talasaz, Lakshminarayanan Nandagopal, Oliver Sartor, Roberto Nussenzveig, Andrew W. Hahn, Gregory R. Pond, Sumanta K. Pal, Richard B. Lanman, Neeraj Agarwal, Theodore Stewart Gourdin, Andrew J. Armstrong
Publikováno v:
Cancer. 125:1459-1469
Background Because cell-free DNA (cfDNA) analysis facilitates the noninvasive genomic profiling of metastatic castration-resistant prostate cancer (mCRPC), the authors evaluated the association between cfDNA alterations and outcomes and evolution wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61fff58b14abe11760eab03a348a529e
https://doi.org/10.1002/cncr.31959
https://doi.org/10.1002/cncr.31959
Autor:
Xinwei Sher, Hun Jung, Justin I. Odegaard, Young Suk Park, Su Jin Lee, Jeeyun Lee, Joon Oh Park, Se Hoon Park, Jonathan D. Cheng, Peter Soonmo Kang, Kyung Kim, Adam J. Bass, Seung Tae Kim, Kyoung-Mee Kim, Andrey Loboda, Razvan Cristescu, Ho Yeong Lim, Amir Ali Talasaz, Xiaoqiao Liu, Hyuk Lee, Mijin Lee, Min-Gew Choi, Won Ki Kang
Publikováno v:
Nature Medicine. 24:1449-1458
Clinical studies support the efficacy of programmed cell death 1 (PD-1) targeted therapy in a subset of patients with metastatic gastric cancer (mGC). With the goal of identifying determinants of response, we performed molecular characterization of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a081b417c7d3605414ce3d59a9d6460
https://doi.org/10.1038/s41591-018-0101-z
https://doi.org/10.1038/s41591-018-0101-z
Autor:
Paul T. Fanta, David Piccioni, In Sil Choi, Razelle Kurzrock, Lyudmila Bazhenova, Shumei Kato, Maria Schwaederle, Richard B. Lanman, Ranajoy Chattopadhyay, Sadakatsu Ikeda, Kimberly C. Banks, Amir Ali Talasaz
Publikováno v:
Cancer research, vol 77, iss 19
Noninvasive genomic profiling of tumors may be possible with next-generation sequencing (NGS) of blood-derived circulating tumor DNA (ctDNA), but proof of concept in a large cohort of patients with diverse cancers has yet to be reported. Here we repo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eba3a608cbbc1748abf629e3cb76868
https://doi.org/10.1158/0008-5472.can-17-0885
https://doi.org/10.1158/0008-5472.can-17-0885
Autor:
Rebecca J. Nagy, Amir Ali Talasaz, Alfred Rademaker, Sarika Jain, William J. Gradishar, Lisa Flaum, RL Curry-Edwards, Giovanna Rossi, Cesar A. Santa-Maria, R Lima Barros Costa, Leonidas C. Platanias, Vittorina Zagonel, Massimo Cristofanilli, Francis J. Giles
Publikováno v:
Cancer Research. 77:P1-05
Background: Estrogen receptor (ER)-α is expressed in about 70% of breast cancers and drugs that target the receptor function, selective estrogen receptor modulators (SERM) and aromatase inhibitors (AIs) represent the standard of care for patients (p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c14662b6c1171a922a17164f9b6ebdfb
https://doi.org/10.1158/1538-7445.sabcs16-p1-05-06
https://doi.org/10.1158/1538-7445.sabcs16-p1-05-06
Autor:
Kian H. Lim, Jeffrey S. Morris, Sadakatsu Ikeda, Hesham M. Amin, Kenna R. Mills-Shaw, Funda Meric-Bernstam, Ahmed Kaseb, Robin Kate Kelley, Benjamin R. Tan, Bhawana George, Lianchun Xiao, Marc Uemura, Andrea Grace Bocobo, Richard B. Lanman, Razelle Kurzrock, Manal M. Hassan, James C. Yao, Robert A. Wolff, Reham Abdel-Wahab, Wei Qiao, Shiraj Sen, Abedul Haque, Asif Rashid, Nora S. Sanchez, Kanwal Pratap Singh Raghav, Kimberly C. Banks, Roberto Carmagnani Pestana, Amir Ali Talasaz
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 25, iss 20
Clin Cancer Res
Clin Cancer Res
Purpose: Molecular profiling has been used to select patients for targeted therapy and determine prognosis. Noninvasive strategies are critical to hepatocellular carcinoma (HCC) given the challenge of obtaining liver tissue biopsies. Experimental Des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea41216438d763f99cc814dcd6c4ae02
https://escholarship.org/uc/item/51m038zw
https://escholarship.org/uc/item/51m038zw
Autor:
Rebecca Nagy, Caroline Weiport, Arielle Yablonovitch, Jennifer Yen, Justin Odegaard, Stephen J. Pettitt, Elena Helman, Alexander Aartyomenko, Andrew Tutt, Christopher Llord, Amir Ali Talasaz, Yu Fu, Darya Chudova, Sante Gnerre
Publikováno v:
Cancer Research. 81:25-25
Background: Inactivating mutations in homologous recombination repair (HRR) genes are associated with a response to PARP inhibitors and platinum-based therapies. However, secondary reversion mutations in HRR genes remain a major mechanism of resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e2cbd365169aa00ca77994a52ef338f
https://doi.org/10.1158/1538-7445.am2021-25
https://doi.org/10.1158/1538-7445.am2021-25